ArticleBMC medicine2026
Tricarboxylic acid cycle metabolite index predicts adverse outcomes in acute myocardial infarction patients.
Article in BMC medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundDisrupted tricarboxylic acid (TCA) cycle metabolism drives ischemic mitochondrial stress in the pathophysiology of acute myocardial infarction (AMI), yet its clinical prognostic utility remains poorly defined. This study aimed to (1) develop a novel metabolic index quantifying TCA cycle disturbance; (2) evaluate its prognostic value for adverse outcomes in patients with AMI; and (3) assess its incremental predictive value beyond established risk factors.
methodsWe analyzed 4071 AMI patients from a hospital-based prospective cohort enrolled between February 2017 and June 2019. Plasma levels of TCA cycle metabolites were measured using a validated liquid chromatography-tandem mass spectrometry (LC-MS/MS) protocol. A composite TCA index was constructed using five specific intermediates: α-ketoglutarate, methylmalonate, succinate, fumarate, and malate. Multivariable Cox regression models were employed to evaluate independent associations and estimate population attributable fractions (PAFs) for clinical outcomes. The incremental predictive value beyond the GRACE score and cardiac biomarkers was assessed using the C-index, net reclassification improvement (NRI), and integrated discrimination improvement (IDI).
resultsDuring a median follow-up of 6.2 years, 1263 (31.0%) major adverse cardiovascular events (MACE), 672 (16.5%) all-cause deaths, 373 (9.2%) cardiovascular deaths, and 561 (13.8%) heart failure events were documented. Each standard deviation (SD) increase in the TCA index was independently associated with a higher risk of MACE (HR: 1.20; 95% CI: 1.13-1.27), all-cause death (HR: 1.22; 95% CI: 1.13-1.32), cardiovascular death (HR: 1.28; 95% CI: 1.16-1.42), and heart failure (HR: 1.21; 95% CI: 1.11-1.31). Notably, PAF analysis revealed distinct patterns: while relative risks were robust in males, the TCA index accounted for a substantially higher mortality burden in females (24.70% vs. 10.05% in males) and younger individuals (≤ 60 years; 25.10%), suggesting these subgroups are particularly vulnerable to metabolic dysregulation. Adding the TCA index to the GRACE score provided incremental prognostic value, evidenced by improved reclassification metrics.
conclusionsThe TCA index serves as a novel indicator of ischemic mitochondrial stress and a robust independent predictor of adverse outcomes in AMI. This metabolic algorithm offers complementary prognostic value to existing clinical models, aiding risk stratification for post-infarction care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.